Stock listing

NASDAQ:SLRN Acelyrin, Inc. Stock

Follow Acelyrin, Inc. into a list and get an email when it puts out news.

Last close · NASDAQ:SLRN

$2.27 USD

Close on May 22, 2025 · No longer trades

May 5, 2023 to last close -90.3% · weekly closes, May 5, 2023 – May 22, 2025
Lowest – highest close
$1.89 – $28.82 USDSince May 5, 2023 · lowest Feb 4, 2025 · highest Aug 22, 2023

Delisted NASDAQ:SLRN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:SLRN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Acelyrin, Inc. on 6ix

Calls
3 calls with a replay · 3 with a transcript · latest Nov 13, 2024
Decks
9 decks · latest Apr 29, 2025

Events

CallWhenStatus
Acelyrin (SLRN) Q3 2024 Earnings CallWed, Nov 13, 2024 · 4:30 PM ETReplay
Acelyrin (SLRN) Q2 2024 Earnings CallTue, Aug 13, 2024 · 5:00 PM ETReplay
Acelyrin (SLRN) Q3 2023 Earnings CallTue, Nov 07, 2023 · 4:30 PM ETReplay

Open Events

Decks

DeckKindSlidesDate
Merger or Acquisition (April 2025)Merger or acquisition36 slidesApr 29, 2025
Merger or Acquisition (April 2025)Merger or acquisition29 slidesApr 21, 2025
Merger or Acquisition (March 2025)Merger or acquisition6 slidesMar 25, 2025
Merger or Acquisition (March 2025)Merger or acquisition10 slidesMar 18, 2025
Merger or Acquisition (March 2025)Merger or acquisition35 slidesMar 11, 2025
Merger or Acquisition (March 2025)Merger or acquisition7 slidesMar 6, 2025
Merger or Acquisition (March 2025)Merger or acquisition31 slidesMar 6, 2025
Merger or Acquisition (February 2025)Merger or acquisition18 slidesFeb 6, 2025
Technical Presentation (March 2024)Technical31 slidesMar 11, 2024

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Beth C Seidenberg
Other companies: Latigo Biotherapeutics, Inc. (Director · Since at least Aug 6, 2026); Kyverna Therapeutics, Inc. (Director · Since at least Feb 7, 2024); Sagimet Biosciences Inc. - Series A (Director · Since at least Jul 13, 2023); Vera Therapeutics, Inc. (Director · Since at least May 13, 2021); Progyny, Inc. (Director · Oct 24, 2019 – May 23, 2024 · Past); Armo Biosciences Inc. (Director · Jan 25, 2018 – Jun 22, 2018 · Past); Atara Biotherapeutics, Inc. (Director · Oct 15, 2014 – May 31, 2023 · Past); Epizyme Inc (Director · May 30, 2013 – Jun 30, 2019 · Past); Tesaro Inc (Director · Jun 27, 2012 – Jan 22, 2019 · Past)
Director · May 4, 2023 – May 21, 2025 · Past
Henry Gosebruch
Other companies: ANI Pharmaceuticals, Inc. (Director · Since at least Aug 19, 2026); Neumora Therapeutics, Inc. (President & CEO, Director · Sep 14, 2023 – Feb 14, 2024 · Past); Aptinyx Inc (Director · May 6, 2019 – May 26, 2022 · Past); AbbVie Inc. (EVP, Chief Strategy Officer · Oct 30, 2017 – May 16, 2022 · Past)
Director · May 4, 2023 – May 21, 2025 · Past
Lynn A. Tetrault
Other companies: Alumis Inc. (Director · Since at least May 21, 2025); NeoGenomics, Inc. (Director · Since at least Jun 2, 2021); Rhythm Pharmaceuticals, Inc. (Director · Since at least Dec 9, 2020)
Director · Dec 18, 2023 – May 21, 2025 · Past
Gil Labrucherie
Other companies: Septerna, Inc. (Chief Financial Officer · Since at least Jan 6, 2025); Rezolute, Inc. (Director · Since at least Jan 23, 2024)
CFO and CBO · Oct 4, 2023 – Aug 31, 2024 · Past
Bruce C. Cozadd
Other companies: Jazz Pharmaceuticals plc (Director · Since at least Oct 1, 2020)
Director · May 4, 2023 – May 21, 2025 · Past
Melanie Gloria
Other companies: Immunovant, Inc. (Chief Operating Officer · Since at least Nov 7, 2024)
Chief Operating Officer · May 4, 2023 – May 23, 2024 · Past
Mina Kim
Other companies: Zymergen Inc (Chief Legal Officer · May 2, 2022 – Sep 2, 2022 · Past)
Chief Executive Officer, Director · May 4, 2023 – May 21, 2025 · Past
Sanam Pangali
Other companies: Alumis Inc. (Chief Legal Officer · Since at least Jul 4, 2025)
CLO & Head of People · May 9, 2024 – May 23, 2024 · Past
Paul PelosoChief Medical Officer · May 4, 2023 – Oct 4, 2023 · Past
Ronald OystonChief People Officer · Jan 9, 2024 – Jan 9, 2024 · Past
All 11 people
PersonSeat
Shephard MpofuChief Medical Officer · May 9, 2024 – May 21, 2025 · Past

Open People

Log in to ask 6ix AI your own questions about Acelyrin, Inc.